The rat spermatogenesis after injection of paclitaxel (antitumor agent)

Area of Science:

• Reproductive biology
• Toxicology
• Oncology

Background:

• Paclitaxel is a widely used chemotherapy agent with known side effects.
• The impact of paclitaxel on male reproductive function requires further elucidation.
• Understanding chemotherapy-induced reproductive toxicity is crucial for patient management.

Purpose of the Study:

• To investigate the effects of paclitaxel on rat spermatogenesis.
• To evaluate morphological and functional changes in sperm after paclitaxel administration.
• To assess the impact of paclitaxel at early and delayed time points post-treatment.

Main Methods:

• Rats were administered a single maximum tolerated dose of paclitaxel.
• Testicular morphology and sperm parameters were analyzed at different time intervals.
• Spermatogenesis was assessed by examining sperm count, morphology, and functional activity.

Main Results:

• Paclitaxel induced significant structural damage in rat testes.
• Oligospermia (low sperm count) was observed.
• An increased number of pathologically formed spermatozoa with reduced functional activity were noted.

Conclusions:

• Paclitaxel causes adverse effects on spermatogenesis in rats.
• The observed testicular changes and impaired sperm quality suggest potential male infertility risks.
• Further research is needed to explore protective strategies against paclitaxel-induced reproductive toxicity.